(Q39729787)

14 September 2017

title

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan (English)

1 reference

14 September 2017

1 reference

1 reference

1 reference

Sheng-Nan Lu

1

1 reference

14 September 2017

Chien-Hung Chen

2

1 reference

14 September 2017

Tsung-Ming Chen

3

1 reference

14 September 2017

Pei-Lun Lee

4

1 reference

14 September 2017

Jing-Houng Wang

5

1 reference

14 September 2017

Hung-Da Tung

6

1 reference

14 September 2017

Chao-Hung Hung

7

1 reference

14 September 2017

Chuan-Mo Lee

8

1 reference

14 September 2017

Chi-Sin Changchien

9

1 reference

14 September 2017

language of work or name

English

0 references

publication date

30 August 2005

1 reference

14 September 2017

1 reference

14 September 2017

volume

24

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

759-765

1 reference

Hepatitis B virus infection

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

From hepatitis to hepatoma: lessons from type B viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Natural history of chronic hepatitis B virus infection: an immunopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Vertical Transmission of Hepatitis B Antigen in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Independent emergence of a vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Twelve-year follow-up study of hepatitis B immunization of Senegalese infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Immune response to hepatitis B revaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Clinical experience with hepatitis B vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Serological pattern ?anti-HBc alone?: Report on a workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.062

10.1016/J.VACCINE.2005.08.062

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference